The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester | Zendy

Özlem Özer | Zendy; Cenk Sayın | Zendy; Füsun Varol | Zendy

Open Access

The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester

Author(s) -

Özlem Özer,

Cenk Sayın,

Füsun Varol

Publication year - 2010

Publication title -

journal of the turkish-german gynecological association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.346

H-Index - 16

eISSN - 1309-0399

pISSN - 1309-0380

DOI - 10.5152/jtgga.2010.36

Subject(s) - ductus venosus , medicine , nuchal translucency measurement , obstetrics , fetus , pregnancy associated plasma protein a , percentile , pregnancy , population , down syndrome , human chorionic gonadotropin , gestation , nuchal translucency , aneuploidy , turner syndrome , gynecology , prenatal diagnosis , first trimester , biology , chromosome , hormone , statistics , genetics , biochemistry , mathematics , environmental health , psychiatry , gene

The aim of the study was to improve nuchal translucency (NT) and serum marker Down syndrome (Tri21) screening methods by including fetal ductus venosus (DV) Doppler measurements.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research